Investments
135Portfolio Exits
26Funds
1About The Vertical Group
The Vertical Group is a venture capital firm that is focused on the fields of medical technology and biotechnology. For more than 30 years, the principals of The Vertical Group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry's companies. The Vertical Group manages private partnerships with a "vertical" range of investments including: early and late venture stage companies; private operating companies involved in buy-out or corporate spin-off transactions; and public companies of all sizes. The Vertical Group is the successor to the venture capital division of F. Eberstadt & Co., and has been an independent firm since 1988.
The Vertical Group Headquarter Location
106 Allen Road Suite 207
Basking Ridge, New Jersey, 7920,
United States
908-277-3737
Expert Collections containing The Vertical Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find The Vertical Group in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Research containing The Vertical Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned The Vertical Group in 1 CB Insights research brief, most recently on Feb 2, 2021.
Feb 2, 2021
Stealth Startup Funding Surged In 2020Latest The Vertical Group News
Jun 24, 2022
AUSTIN, TX, MicroTransponder closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and Exceller Hunt Ventures return as existing investors alongside new venture investors that include Osage University Partners, Action Potential Venture Capital and The Vertical Group. Vivistim is MicroTransponder's first FDA-approved use of its novel neuroplasticity-based medical device platform. Vivistim is designed to enhance daily living for people suffering from neurological conditions that impair sensory and motor function. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
The Vertical Group Investments
135 Investments
The Vertical Group has made 135 investments. Their latest investment was in MicroTransponder as part of their Series E on June 6, 2022.
The Vertical Group Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/20/2022 | Series E | MicroTransponder | $53M | Yes | 4 | |
4/19/2022 | Series B | Carlsmed | $30M | No | 4 | |
12/22/2021 | Seed VC | El Camino Real Medical | $0.32M | Yes | 1 | |
12/22/2021 | Seed VC | |||||
7/13/2021 | Series E |
Date | 6/20/2022 | 4/19/2022 | 12/22/2021 | 12/22/2021 | 7/13/2021 |
|---|---|---|---|---|---|
Round | Series E | Series B | Seed VC | Seed VC | Series E |
Company | MicroTransponder | Carlsmed | El Camino Real Medical | ||
Amount | $53M | $30M | $0.32M | ||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 4 | 4 | 1 |
The Vertical Group Portfolio Exits
26 Portfolio Exits
The Vertical Group has 26 portfolio exits. Their latest portfolio exit was Biorez on August 01, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/1/2022 | Acquired | 4 | |||
7/11/2022 | Acquired | 9 | |||
9/15/2020 | IPO | Public | 5 | ||
Date | 8/1/2022 | 7/11/2022 | 9/15/2020 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 4 | 9 | 5 |
The Vertical Group Acquisitions
2 Acquisitions
The Vertical Group acquired 2 companies. Their latest acquisition was Wright Medical Group on December 20, 1999.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/20/1999 | Other Venture Capital | $26.61M | Acquired | 3 | ||
12/19/1990 | Growth Equity |
Date | 12/20/1999 | 12/19/1990 |
|---|---|---|
Investment Stage | Other Venture Capital | Growth Equity |
Companies | ||
Valuation | ||
Total Funding | $26.61M | |
Note | Acquired | |
Sources | 3 |
The Vertical Group Fund History
1 Fund History
The Vertical Group has 1 fund, including Vertical Fund I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2005 | Vertical Fund I | Multi-Stage Venture Capital | Closed | $381M | 1 |
Closing Date | 12/31/2005 |
|---|---|
Fund | Vertical Fund I |
Fund Type | Multi-Stage Venture Capital |
Status | Closed |
Amount | $381M |
Sources | 1 |
The Vertical Group Team
9 Team Members
The Vertical Group has 9 team members, including current Founder, Managing Director, General Partner, Richard Emmitt.
Name | Work History | Title | Status |
|---|---|---|---|
Tony M. Chou | Founder | Current | |
Richard Emmitt | Founder, Managing Director, General Partner | Current | |
John A Slattery | Chief Financial Officer | Current | |
Dick Anderson | CFM, KnowledgePlanet, and Vanstar | Executive Vice President | Current |
Yue-Teh Jang | General Partner | Current |
Name | Tony M. Chou | Richard Emmitt | John A Slattery | Dick Anderson | Yue-Teh Jang |
|---|---|---|---|---|---|
Work History | CFM, KnowledgePlanet, and Vanstar | ||||
Title | Founder | Founder, Managing Director, General Partner | Chief Financial Officer | Executive Vice President | General Partner |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.